As cancer immunotherapy continues to evolve, the immunosuppressive tumor microenvironment (TME) remains a major barrier to effective treatment. Now, researchers from Chengdu University, led by Dr. Xiao Wei and Dr. Mingzhu Song, have presented a comprehensive review on synergistic ferroptosis–immunotherapy nanoplatforms. This work offers a systematic roadmap for integrating ferroptosis induction with immunotherapy to overcome TME resistance and enhance antitumor immunity.
Why Ferroptosis–Immunotherapy Synergy Matters
Innovative Design and Features
Applications and Future Outlook
This comprehensive review provides a scientific basis for the rational design of ferroptosis–immunotherapy nanoplatforms. It highlights the importance of interdisciplinary collaboration in materials science, immunology, and oncology to accelerate clinical translation. Stay tuned for more groundbreaking work from Dr. Xiao Wei and Dr. Mingzhu Song at Chengdu University!
Nano-Micro Letters
Experimental study
Synergistic Ferroptosis–Immunotherapy Nanoplatforms: Multidimensional Engineering for Tumor Microenvironment Remodeling and Therapeutic Optimization
2-Sep-2025